As the U.S. government considers banning genomics companies from China, it opens a broader question about how the United States and other market economies should deal with China’s “national champions.” This paper provides an overview of one such company—BGI—and how China’s industrial policy impacts technology development in China and around the world.

The celebrated return to China of its overseas scientists, as evidenced in the recent case of physicist Gao Huajian, is typically cited as a loss to the United States. This report argues a contrarian view that the benefits equation is far more complicated. PRC programs that channel diaspora achievements “back” to China and the inclination of many scientists to work in familiar venues blur the distinction between returning to China and staying in place.

Jacob Feldgoise and Hanna Dohmen at the Center for Security and Emerging Technology (CSET) at Georgetown University offer the following response to the Bureau of Industry and Security’s (BIS) Notice of Proposed Rulemaking (NPRM): Taking Additional Steps To Address the National Emergency With Respect to Significant Malicious Cyber-Enabled Activities (89 FR 5698).

China’s brain-computer interface research has two dimensions. Besides its usual applications in neuropathology, China is extending the benefits of BCI to the general population, aiming at enhanced cognition and a “merger” of natural and artificial intelligence. This report, authored in collaboration with researchers from the Department of War Studies at King’s College London uses bibliometric analysis and expert assessment of technical documents to evaluate China’s BCI, and conclude that the research is on track to achieve its targets.

CSET's Ngor Luong testified before the U.S.-China Economic and Security Review Commission where she discussed Chinese investments in military applications of AI.

CSET's Jack Corrigan testified before the U.S.-China Economic and Security Review Commission where he discussed security threats posed by Chinese information and communications technology systems.

On January 17, 2024, CSET Researchers submitted a response to proposed rules from the Bureau of Industry and Security at the U.S. Department of Commerce. In the submission, CSET recommends that Commerce not implement controls on U.S. companies providing IaaS to Chinese entities, among other recommendations.

Recent government directives, international conferences, and media headlines reflect growing concern that artificial intelligence could exacerbate biological threats. When it comes to biorisk, AI tools are cited as enablers that lower information barriers, enhance novel biothreat design, or otherwise increase a malicious actor’s capabilities. In this explainer, CSET Biorisk Research Fellow Steph Batalis summarizes the state of the biorisk landscape with and without AI.

This data brief analyzes over 200,000 U.S. government grants awarded to industry and academic recipients for artificial intelligence research between January 2017 and May 2023. The authors find that while the majority of federal grants are awarded to academic recipients, industry played an outsized role in U.S. government grant funding of AI research. Moreover, departments within the U.S. Department of Defense appear to prioritize funding industry and AI research relative to other funding agencies.

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This is the second installment of a two-part series of data snapshots that explores export control data from the Bureau of Industry and Security (BIS), namely the 2021 and 2022 yearly reports for trade with China and Hong Kong.